As coronavirus infections elsewhere topped 87,000, surpassing China’s 80,860 cases, governments are taking different approaches to slowing its spread. Germany has closed its borders with five neighbors as European infections mount, the U.S. is moving closer to a nationwide shutdown and the Philippine island of Luzon is under strict quarantine. Meanwhile, the U.K. is seeing a backlash for what critics say is a dangerously slow response.
What about a vaccine? While companies and researchers around the world are racing to develop one, as well as treatments, a Massachusetts biotech firm is launching human immunization trials today in Seattle.